TL - I'd think PoS would be just one of many on a very long list. This guys downramping on POH is legendary- and yet contrary to Lopez's year long dire predictions- POH is still here and is writing deals and advancing its platform across multiple silos. POH also looks to be have several channels of cash flow coming on line for 2013. Isn't that every Bio Investors dream? A scaleable platform tech with money in the bank for its commercial stragegies and near term postive cashflow?
